Design, synthesis, and cytotoxicity of stabilized mycolactone analogs

Bioorg Med Chem Lett. 2017 Mar 1;27(5):1274-1277. doi: 10.1016/j.bmcl.2017.01.036. Epub 2017 Jan 17.

Abstract

On exposure to visible light, mycolactone A/B, the causative toxin of Buruli ulcer, rearranges to a mixture of four photo-mycolactones apparently via a rare photochemically-induced [4πs+2πa] cycloaddition. In order to prevent the rearrangement, two C6'-C7' dihydromycolactone analogs 6'α-15 and 6'β-15 were designed and synthesized. 6'α-15 and 6'β-15 were shown to be stable under not only photochemical, but also acidic and basic conditions. Cytotoxicity was tested against arbitrarily chosen four cell lines (human Hek-293, human lung carcinoma A-549, human melanoma LOX-IMVI, and mouse L-929), thereby revealing that: (1) both analogs maintain potent cytotoxicity; (2) 6'β-15 exhibits significantly higher potency against human cell lines than 6'α-15; (3) in comparison with parent mycolactone A/B, 6'β-15 exhibits equal potency against human Hek-293, whereas significantly lower potency against human lung carcinoma A-549 and human melanoma LOX-IMVI.

Keywords: Buruli ulcer; Cytotoxicity; Dihydromycolactones; Mycolactones; Photochemical [(4)π(s)+(2)π(a)] cycloaddition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Cell Line
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Drug Design*
  • Humans
  • Inhibitory Concentration 50
  • Macrolides / chemical synthesis*
  • Macrolides / chemistry
  • Macrolides / pharmacology
  • Mice
  • Molecular Structure

Substances

  • Antineoplastic Agents
  • Macrolides
  • mycolactone
  • mycolactone B